Dynamic Technology Lab’s Dianthus Therapeutics DNTH Stock Holding History
Bought
Maintained
Sold
Other funds holding DNTH
TGI
GGHC
CC
AI
EAM
AG
Dynamic Technology Lab's DNTH Position: Q2 2020 in Review
Dynamic Technology Lab sold out of Dianthus Therapeutics (DNTH) in Q2 2020, closing a stake of 691 shares — an estimated $69K sold.
Dynamic Technology Lab first reported a position in DNTH in Q1 2020 and held it in 1 quarter. The position peaked at $69K in Q1 2020. 95 funds tracked by Wall St. Rank hold DNTH as of Q2 2020.
- Dynamic Technology Lab reported no remaining Dianthus Therapeutics position as of Q2 2020 after selling out during the quarter.
- Dynamic Technology Lab sold 691 Dianthus Therapeutics shares in Q2 2020, an estimated $69K.
- Dynamic Technology Lab first reported a position in Dianthus Therapeutics in Q1 2020 and held it in 1 quarter.
- Dynamic Technology Lab's Dianthus Therapeutics position peaked at $69K in Q1 2020.
- 95 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q2 2020.
Based on Dynamic Technology Lab's 13F filing for Q2 2020, filed 14 Aug 2020.